[1]
Thomas, X. et al. 2020. LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY: Gemtuzumab ozogamicin in AML. Mediterranean Journal of Hematology and Infectious Diseases. 12, 1 (Apr. 2020), e2020020. DOI:https://doi.org/10.4084/mjhid.2020.020.